<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were evaluated by the ophthalmology service within 2 months of the <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> diagnosis for bilateral <z:hpo ids='HP_0000572'>visual loss</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The mean age of diagnosis of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> was 14.3 years (range: 5 to 19 years) and the mean follow-up was 25 months (range: 15 to 44 months) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 6 eyes demonstrated <z:e sem="disease" ids="C0730289" disease_type="Disease or Syndrome" abbrv="">choroidal ischemia</z:e> and <z:hpo ids='HP_0007902'>vitreous hemorrhage</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Pars plana vitrectomy was performed in four eyes of two patients for non-clearing <z:hpo ids='HP_0007902'>vitreous hemorrhage</z:hpo>; one patient was observed </plain></SENT>
<SENT sid="4" pm="."><plain>Successful anatomic outcomes were achieved in 3 of 4 eyes that underwent vitrectomy </plain></SENT>
<SENT sid="5" pm="."><plain>Initial visual acuity ranged from 20/80 to bare light perception and final visual acuity ranged from 20/20 to no light perception </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received immunosuppressive therapy including <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and anti-thymocyte globulin, and two underwent hematopoietic stem cell transplantation </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received perioperative platelet and blood transfusions </plain></SENT>
<SENT sid="8" pm="."><plain>Pars plana vitrectomy resulted in functional and anatomic success in the majority of eyes in this series </plain></SENT>
<SENT sid="9" pm="."><plain>Coordination of medical and surgical care with the hematology service is advisable to stabilize hematologic parameters prior to undertaking a vitreoretinal procedure </plain></SENT>
</text></document>